Contact Congress about H.R. 7902: Safeguarding Women from Chemical Abortion Act

Mifepristone could no longer have federal approval for ending a pregnancy inside the uterus. People who say the drug harmed them could sue the maker for money damages and legal costs.

Modern Action explains legislation in plain English, helps you choose whether to support, oppose, or ask for changes, and drafts a message tied to the bill, your stance, and the elected officials who can act on it.

Safeguarding Women from Chemical Abortion Act is a House bill in committee. The latest recorded action: Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Latest action on H.R. 7902: Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Who this affects: This bill mainly affects patients who use or seek mifepristone to end a pregnancy inside the uterus, health care providers who prescribe or provide it, pharmacies and distributors that handle it, and companies that make it. Patients could face a changed legal status for the drug and could gain a new path to sue if they say it harmed them. Makers could face new lawsuits and higher legal risk. Providers, pharmacies, and distributors could have to adjust to the loss of federal approval for that use and to federal rules on wrongly labeled drugs.

Why this matters: This bill could change whether mifepristone is legally available for medication abortion in the United States. It would make federal drug law treat that use differently from other approved uses by ending approval and treating abortion-use labels as wrongly labeled. It could also increase lawsuits against drug makers. The size of the real-world effect would depend on how agencies enforce the law, how courts read it, and how state laws interact with it.

Key provisions in H.R. 7902

• FDA approval of mifepristone for ending an intrauterine pregnancy would end 14 days after enactment. An intrauterine pregnancy is a pregnancy inside the uterus.
• The rule would cover Mifeprex, also called RU-486. It would also cover generic versions used for the same purpose.
• After that approval ends, shipping or selling these drugs across state lines for that abortion use would break federal drug-approval law. That rule comes from section 505 of the Food, Drug, and Cosmetic Act.
• Mifepristone would count as misbranded, meaning wrongly labeled, if its label says it can end an intrauterine pregnancy. The same would be true if the label says it can be used with another drug for that purpose.
• A covered entity would mean any person or company that makes the covered medication for sale or shipment across state lines.

How Modern Action helps you take action on H.R. 7902

You do not have to start with a blank letter. Modern Action turns the bill, your position, and the relevant congressional context into a message you can edit and send. The goal is to make contacting Congress clear, specific, and useful without forcing you to parse bill text or figure out the right office on your own.

Questions people ask about H.R. 7902

What is H.R. 7902?

Mifepristone could no longer have federal approval for ending a pregnancy inside the uterus. People who say the drug harmed them could sue the maker for money damages and legal costs.

How do I support or oppose H.R. 7902?

Choose support, oppose, or ask for changes on Modern Action. The action flow drafts the message for you and keeps the wording tied to this bill.

Who should I contact about H.R. 7902?

Modern Action uses your location to route the action to the congressional offices relevant to the bill and your representation.

Can Modern Action explain H.R. 7902 before I act?

Yes. Modern Action gives you a plain-English summary, current status, and action context before you send anything.